Beta Bionic, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Beta Bionic, Inc. | BBNX - NASDAQ |
$16.00-$17.00 | $17.00 | $22.00 | 12 million | 1/30/2025 |
| BofA Securities, Piper Sandler, Leerink Partners | ||||||
Co-Manager(s): Stifel, Lake Street | ||||||
| Health Care | ||||||
Filing(s): Filed 2025-01-07 Terms Added 2025-01-22 Amended Prospectus 2025-01-28 | ||||||
Beta Bionic, Inc. Quote & Chart - Click for current quote - BBNX
IPO Boutique aggregates information on public companies and private companies, such as "BBNX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Beta Bionic, Inc. (adapted from Beta Bionic, Inc. prospectus):
They are a commercial-stage medical device company engaged in the design, development, and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing advanced adaptive closed-loop algorithms to simplify and improve the treatment of their disease.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a commercial-stage medical device company engaged in the design, development, and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing advanced adaptive closed-loop algorithms to simplify and improve the treatment of their disease.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "BBNX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.